Delivery Order SPE2DB20D1100-SPE2DB24FC6M7

Award Date 7/9/24
Potential Completion Date 7/10/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,357.86 to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is for the provision of the prescription medication Aimovig 140 mg/ml autoinjector, with a completion date of July 3, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which allows the...
The U.S. Defense Logistics Agency (DLA) awarded a $1,070.94 firm-fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, an established pharmaceutical distributor. This order is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which enables the agency to efficiently procure a wide range of essential pharmaceutical products and medical supplies for the Department of Defense worldwide. The current...
The Defense Logistics Agency (DLA) has awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the procurement of AIMOVIG 70 MG/ML AUTOINJECTOR medical products. The contract has a Ceiling Value of $2,711.46 and a period of performance through April 18, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical to provide a comprehensive range of...
The Defense Logistics Agency (DLA) awarded a $3,615.28 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical supplier, for the provision of AIMOVIG 70 MG/ML AUTOINJECTORML. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities...
The Defense Logistics Agency (DLA) awarded a $2,559.81 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the supply of AIMOVIG 140 MG/ML autoinjectors, with a completion date of May 1, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued up to $999,999,999.00 through December 2025, which serves as...
The Defense Logistics Agency (DLA) awarded a $3,125.09 firm-fixed price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of AIMOVIG 140 MG/ML autoinjectors. The order has an ultimate completion date of August 23, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, for providing a comprehensive range of medical commodities to support military treatment programs and...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division for $1,357.86 to provide AIMOVIG 140 MG/ML AUTOINJECTOR medication. This is a firm-fixed-price contract with a completion date of September 23, 2024. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to supply critical medical commodities, including medications, vaccines, and medical supplies, to support military...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,895.97 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the supply of AIMOVIG 70 MG/ML AUTOINJECTORML, a pharmaceutical product, with a completion date of February 1, 2024. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp,...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Aimovig 140 mg/mL autoinjectors. This is a firm fixed price contract with a ceiling value of $5,056.57 and a performance period through April 12, 2024. AmerisourceBergen Drug Corp was awarded this delivery order under an existing $999,999,999.00 indefinite delivery contract (IDC) with DLA, which serves as the primary vehicle for the...
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of AIMOVIG 140 MG/ML autoinjectors. The $2,817.77 contract has a completion date of February 21, 2024 and does not have any set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 from the...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC6M7
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor, to provide AIMOVIG 140 mg/mL autoinjectors. The $1,357.86 firm-fixed-price contract has a completion date of July 10, 2024. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to deliver a broad range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense globally. Additionally, the company has a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities, valued up to $750,000. These contracts leverage Amerisourcebergen's extensive pharmaceutical distribution capabilities to efficiently supply critical medications and medical supplies to various federal agencies. The current award was issued on an unrestricted, full and open competition basis without a set-aside designation.

Generated 10/8/24, 9:02 AM